Vol 12, No 2 (February 28, 2023): Translational Lung Cancer Research

Editorial

Understanding KRAS for better targeting
Ronak Patel, Jorge Nieva
PDF Pages: 181-183 Full Text (675) COI Form Open Access Get Permission
Surgical series in mesothelioma: navigating between biases
Jo Raskin, Paul E. Van Schil, Jan P. Van Meerbeeck
PDF Pages: 184-186 Full Text (488) COI Form Open Access Get Permission
Some like it hot: the potential role of hyperthermic intrathoracic chemotherapy in the multimodality treatment of pleural mesothelioma
Kevin Branch, Prasad S. Adusumilli, Marjorie G. Zauderer
PDF Pages: 187-189 Full Text (732) COI Form Open Access Get Permission
Pleurectomy decortication is the preferred surgical procedure in pleural mesothelioma
Moshe Lapidot, Raphael Bueno
PDF Pages: 190-192 Full Text (701) COI Form Open Access Get Permission
Do we still need to debate the merits of pleurectomy/decortication vs. extrapleural pneumonectomy for malignant pleural mesothelioma?
Akifumi Nakamura, Kozo Kuribayashi
PDF Pages: 193-196 Full Text (1118) COI Form Open Access Get Permission
Spare the lung: surgical treatment approach for malignant pleural mesothelioma
Nobukazu Fujimoto
PDF Pages: 197-199 Full Text (570) COI Form Open Access Get Permission
Molecular minimal residual disease in resected non-small cell lung cancer (NSCLC): results of specifically designed interventional clinical trials eagerly awaited
Marc G. Denis, Guillaume Herbreteau, Elvire Pons-Tostivint
PDF Pages: 200-203 Full Text (818) COI Form Open Access Get Permission
Adjuvant chemotherapy for locally advanced non-small cell lung cancer: still state of the art or an outdated therapy?
Georg Schlachtenberger, Khosro Hekmat, Thorsten Wahlers, Matthias B. Heldwein
PDF Pages: 204-206 Full Text (487) COI Form Open Access Get Permission

Original Article

Supervision by an experienced surgeon can reduce the learning curve of uniportal thoracoscopic lobectomy
Hitoshi Igai, Natsumi Matsuura, Kazuki Numajiri, Fumi Ohsawa, Mitsuhiro Kamiyoshihara
PDF Pages: 207-218 Full Text (396) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring BRAF mutations
Haowei Wang, Lei Cheng, Chao Zhao, Fei Zhou, Tao Jiang, Haoyue Guo, Jinpeng Shi, Peixin Chen, Zhuoran Tang, Shiqi Mao, Keyi Jia, Lingyun Ye, Chenlei Cai, Xuefei Li, Xiaoxia Chen, Caicun Zhou
PDF Pages: 219-229 Full Text (913) Reporting Checklist Data Sharing Statement COI Form Open Access Get Permission
A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma
Xinyi Wang, Hui Jing, Hecheng Li
PDF Pages: 230-246 Full Text (1711) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Cost-effectiveness of diagnostic tests during follow-up in lung cancer patients: an evidence-based study
Fernando Rodríguez-Cano, Virginia Calvo, Yago Garitaonaindía, José Luis Campo-Cañaveral de la Cruz, Mariola Blanco, María Torrente, Mariano Provencio
PDF Pages: 247-256 Full Text (734) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Peripheral T-cell receptor repertoire dynamics in small cell lung cancer
Meridith L. Balbach, Margaret L. Axelrod, Justin M. Balko, Armand Bankhead, Tristan Shaffer, Lee Lim, Jiannan Guo, Jennifer Hernandez, Mark Li, Wade T. Iams
PDF Pages: 257-265 Full Text (1548) Reporting Checklist Data Sharing Statement COI Form Open Access Get Permission
Pembrolizumab plus pemetrexed-carboplatin combination in first-line treatment of advanced non-squamous non-small cell lung cancer: a multicenter real-life study (CAP29)
Emmanuelle Renaud, Charles Ricordel, Romain Corre, Guillaume Leveiller, Florence Gadby, Hélène Babey, Josselin Annic, François Lucia, Vincent Bourbonne, Gilles Robinet, Renaud Descourt, Charles Orione, Gilles Quéré, Margaux Geier
PDF Pages: 266-276 Full Text (1743) Reporting Checklist Data Sharing Statement COI Form Open Access Get Permission
Integrated analysis reveals the microenvironment of non-small cell lung cancer and a macrophage-related prognostic model
Shenglong Xie, Guixiang Huang, Weiwei Qian, Xuyang Wang, Hanlu Zhang, Zhiyang Li, Yu Liu, Yun Wang, Hongtao Yu
PDF Pages: 277-294 Full Text (1286) Reporting Checklist Data Sharing Statement COI Form Open Access Get Permission
Integrative genomic profiling reveals characteristics of lymph node metastasis in small cell lung cancer
Kangle Kong, Shan Hu, Jiaqi Yue, Ziheng Yang, Salma K. Jabbour, Yu Deng, Bo Zhao, Fan Li
PDF Pages: 295-311 Full Text (1119) Reporting Checklist Data Sharing Statement COI Form Open Access Get Permission
Differential organ-specific tumor response to first-line immune checkpoint inhibitor therapy in non-small cell lung cancer—a retrospective cohort study
Qi Wang, Yujia Fang, Chunyu Li, Tracy L. Leong, Mariano Provencio, In-Jae Oh, Zhemin Zhang, Chunxia Su
PDF Pages: 312-321 Full Text (937) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission

Review Article

Narrative review: immunotherapy in anaplastic lymphoma kinase (ALK)+ lung cancer—current status and future directions
Erin L. Schenk
PDF Pages: 322-336 Full Text (1629) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Early-stage anaplastic lymphoma kinase (ALK)-positive lung cancer: a narrative review
Monica F. Chen, Jamie E. Chaft
PDF Pages: 337-345 Full Text (2104) Reporting Checklist COI Form Open Access Get Permission
Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development—a narrative review
Mariacarmela Santarpia, Giuliana Ciappina, Calogera Claudia Spagnolo, Andrea Squeri, Maria Ilenia Passalacqua, Andrés Aguilar, Maria Gonzalez-Cao, Elisa Giovannetti, Nicola Silvestris, Rafael Rosell
PDF Pages: 346-368 Full Text (3497) Reporting Checklist COI Form Open Access Get Permission
Optimal first-line treatment for metastatic ALK+ non-small cell lung cancer—a narrative review
Grace Chazan, Benjamin J. Solomon
PDF Pages: 369-378 Full Text (12418) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Targeting lung cancer brain metastases: a narrative review of emerging insights for anaplastic lymphoma kinase (ALK)-positive disease
Thomas A. Nelson, Nancy Wang
PDF Pages: 379-392 Full Text (1498) Reporting Checklist Peer Review File COI Form Open Access Get Permission

Erratum

Erratum to neoadjuvant chemo-immunotherapy for lung cancer: how much is too much?
Editorial Office
PDF Pages: 393-394 Full Text (465) Open Access Get Permission